Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.

doi:10.1200/JCO.1998.16.4.1532

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 1998

Zinzani P L, Pileri S, Bendandi M, Buzzi M, Sabattini E, Ascani S, Gherlinzoni F, Magagnoli M, Albertini P, Tura S

Abstract excerpt

PURPOSE: In the last few years, the search for new biologic markers in high-grade non-Hodgkin's lymphomas has provided important results. In particular, soluble CD30 (sCD30) levels were elevated in most patients with Hodgkin's disease (HD) and anaplastic large-cell lymphoma (ALCL). PATIENTS AND M...

Topics

Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cyclophosphamide
Cytarabine
Doxorubicin
Female
Fluorouracil
Humans
Ki-1 Antigen
Leucovorin
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Male

Methotrexate

Middle Aged

Phenotype

Source

Open in PubMed

Identifiers

PMID: 9552063
DOI: 10.1200/JCO.1998.16.4.1532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9552063-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.